Targeting signal transduction pathways for the treatment of Kaposi sarcoma

Janet Douglas, Henry B. Koon, Ashlee Moses

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Kaposi sarcoma (KS) is a multi-focal angioproliferative disease driven by infection of cells by Kaposi sarcoma herpesvirus/human herpesvirus-8 (KSHV/HHV8). KSHV/HHV8 infection activates numerous sequential and parallel signaling pathways creating an angiogenic-inflammatory state that leads to the development of Kaposi sarcoma. These pathways can be grouped into KSHV/HHV8-specific pathways and cellular growth/angiogenic pathways that are pirated by KSHV/HHV8. Advances in our understanding of the pathogenesis of KS parallel the clinical development of signal transduction inhibitors. This chapter reviews the signaling pathways active in KSHV/HHV8-infected cells and discusses the use of clinical inhibitors of these pathways in the treatment of KS.

Original languageEnglish (US)
Title of host publicationMolecular Basis for Therapy of AIDS-Defining Cancers
PublisherSpringer New York
Pages79-93
Number of pages15
ISBN (Print)9781441915122
DOIs
StatePublished - 2010

Fingerprint

Signal transduction
Kaposi's Sarcoma
Signal Transduction
Human Herpesvirus 8
Herpesviridae
Cells
Herpesviridae Infections
Critical Pathways

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Douglas, J., Koon, H. B., & Moses, A. (2010). Targeting signal transduction pathways for the treatment of Kaposi sarcoma. In Molecular Basis for Therapy of AIDS-Defining Cancers (pp. 79-93). Springer New York. https://doi.org/10.1007/978-1-4419-1513-9_5

Targeting signal transduction pathways for the treatment of Kaposi sarcoma. / Douglas, Janet; Koon, Henry B.; Moses, Ashlee.

Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York, 2010. p. 79-93.

Research output: Chapter in Book/Report/Conference proceedingChapter

Douglas, J, Koon, HB & Moses, A 2010, Targeting signal transduction pathways for the treatment of Kaposi sarcoma. in Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York, pp. 79-93. https://doi.org/10.1007/978-1-4419-1513-9_5
Douglas J, Koon HB, Moses A. Targeting signal transduction pathways for the treatment of Kaposi sarcoma. In Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York. 2010. p. 79-93 https://doi.org/10.1007/978-1-4419-1513-9_5
Douglas, Janet ; Koon, Henry B. ; Moses, Ashlee. / Targeting signal transduction pathways for the treatment of Kaposi sarcoma. Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York, 2010. pp. 79-93
@inbook{555a6203b0b34084984607c071105bb0,
title = "Targeting signal transduction pathways for the treatment of Kaposi sarcoma",
abstract = "Kaposi sarcoma (KS) is a multi-focal angioproliferative disease driven by infection of cells by Kaposi sarcoma herpesvirus/human herpesvirus-8 (KSHV/HHV8). KSHV/HHV8 infection activates numerous sequential and parallel signaling pathways creating an angiogenic-inflammatory state that leads to the development of Kaposi sarcoma. These pathways can be grouped into KSHV/HHV8-specific pathways and cellular growth/angiogenic pathways that are pirated by KSHV/HHV8. Advances in our understanding of the pathogenesis of KS parallel the clinical development of signal transduction inhibitors. This chapter reviews the signaling pathways active in KSHV/HHV8-infected cells and discusses the use of clinical inhibitors of these pathways in the treatment of KS.",
author = "Janet Douglas and Koon, {Henry B.} and Ashlee Moses",
year = "2010",
doi = "10.1007/978-1-4419-1513-9_5",
language = "English (US)",
isbn = "9781441915122",
pages = "79--93",
booktitle = "Molecular Basis for Therapy of AIDS-Defining Cancers",
publisher = "Springer New York",

}

TY - CHAP

T1 - Targeting signal transduction pathways for the treatment of Kaposi sarcoma

AU - Douglas, Janet

AU - Koon, Henry B.

AU - Moses, Ashlee

PY - 2010

Y1 - 2010

N2 - Kaposi sarcoma (KS) is a multi-focal angioproliferative disease driven by infection of cells by Kaposi sarcoma herpesvirus/human herpesvirus-8 (KSHV/HHV8). KSHV/HHV8 infection activates numerous sequential and parallel signaling pathways creating an angiogenic-inflammatory state that leads to the development of Kaposi sarcoma. These pathways can be grouped into KSHV/HHV8-specific pathways and cellular growth/angiogenic pathways that are pirated by KSHV/HHV8. Advances in our understanding of the pathogenesis of KS parallel the clinical development of signal transduction inhibitors. This chapter reviews the signaling pathways active in KSHV/HHV8-infected cells and discusses the use of clinical inhibitors of these pathways in the treatment of KS.

AB - Kaposi sarcoma (KS) is a multi-focal angioproliferative disease driven by infection of cells by Kaposi sarcoma herpesvirus/human herpesvirus-8 (KSHV/HHV8). KSHV/HHV8 infection activates numerous sequential and parallel signaling pathways creating an angiogenic-inflammatory state that leads to the development of Kaposi sarcoma. These pathways can be grouped into KSHV/HHV8-specific pathways and cellular growth/angiogenic pathways that are pirated by KSHV/HHV8. Advances in our understanding of the pathogenesis of KS parallel the clinical development of signal transduction inhibitors. This chapter reviews the signaling pathways active in KSHV/HHV8-infected cells and discusses the use of clinical inhibitors of these pathways in the treatment of KS.

UR - http://www.scopus.com/inward/record.url?scp=84900070121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900070121&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-1513-9_5

DO - 10.1007/978-1-4419-1513-9_5

M3 - Chapter

AN - SCOPUS:84900070121

SN - 9781441915122

SP - 79

EP - 93

BT - Molecular Basis for Therapy of AIDS-Defining Cancers

PB - Springer New York

ER -